Showing 1-10 of 15 results for "".
- Leon Kircik, MD, FAADhttps://practicaldermatology.com/profiles/leon-kircik-md-faad/L09oqo/
Therapeutic Advances and Fighting for Authorizations
https://practicaldermatology.com/programs/practical-dermatology/therapeutic-advances-and-fighting-for-authorizations/35890/Joel L. Cohen, MD, FAAD, and Leon Kircik, MD, FAAD, discuss the latest developments in psoriasis and atopic dermatitis, as well as the challenges involved with fighting for prior authorizations for the best therapies, at Music City SCALE 2025.COVID and Biologics
https://practicaldermatology.com/series/dermatology-education-foundation/covid-and-biologics/19981/Is it safe to continue biologic therapies amid the COVID-19 pandemic? Are vaccines safe for these patients? Leon Kircik, MD talks about why he tells his patients to continue to use their medications and encourages them to get the COVID vaccine.ICD-10: When the Rubber Meets the Road
https://practicaldermatology.com/topics/practice-management/icd-10-when-the-rubber-meets-the-road/18632/When plans to move to ICD-10 were first announced, providers expressed concerns about potential logistical concerns with the new coding system. However, now that the new system is in regular use, Leon Kircik, MD said health claim denial rates have been lower than expected and the transition has beenNew Topical Options for Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-topical-options-for-psoriasis/19979/Leon Kircik, MD shares his excitement about new molecules for psoriasis. He discusses the available data for tapinarof, a first-in-class small-molecule topical therapeutic aryl hydrocarbon receptor (AhR)–modulating agent, and roflumilast cream, a once-daily topical formulation of roflumilast, a high- Vial Connects with Advisory Board at 2022 Maui Dermatology Conferencehttps://practicaldermatology.com/news/vial-connects-with-advisory-board-at-2022-maui-dermatology-conference/2461050/Vial, in conjunction with the 2022 Maui Dermatology Conference, is hosting an Advisory Board co-hosted by Leon Kircik, MD, FAAD. Dr. Kircik and Vial, along with leading research sites, will discuss and collaborate on how Vial can continue to help grow dermatology research sites and tackle the big
- Vehicles, Infectious Disease, and Acne Updates from Day 2 at DERM2019https://practicaldermatology.com/news/vehicles-infectious-disease-and-acne-updates-from-day-2-at-derm2019/2460099/The DERM2019 NP/PA CME Conference continued to delight audiences with esteemed faculty presenters, including those who presented Friday, including April Armstrong, David Cohen, Kara Gooding, Joseph Gorelick, Julie Harper, Jayme Heim, George Keough, Leon Kircik, Kristine Kucera, Gilly Munavalli, T
New Biologics
https://practicaldermatology.com/topics/psoriasis/new-biologics/18635/Craig Leonardi, MD, shares insight on developments in biologics that may offer significantly improved efficacy compared with existing agents. Dr. Leonardi also discusses the rapidly evolving treatment paradigm in the management of psoriasis.Merkel Cell Carcinoma Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/merkel-cell-carcinoma-update/20217/News that “Margaritaville” singer Jimmy Buffett died from Merkel cell carcinoma is shining a spotlight on this rare and aggressive form of skin cancer. Leonel Hernandez Aya, MD, a medical oncologist specializing in skin cancers at the Sylvester Comprehensive Cancer Center at the University of Miami- KYTHERA Biopharmaceuticals to Present at 32nd Annual J.P. Morgan Healthcare Conferencehttps://practicaldermatology.com/news/20140107-kythera_biopharmaceuticals_to_present_at_32nd_annual_jp_morgan_healthcare_conference/2459378/KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
- Prev
- Next